Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3520 ARTÍCULOS , VIENDO DEL 211 AL 225

Lower extremity predominant stiff-person syndrome and limbic encephalitis with amphiphysin antibodies in breast cancer

Krishna VR, Knievel K, Ladha S, Sivakumar K.

J Clin Neuromuscul Dis. 2012 Dec;14(2):72-4. doi: 10.1097/CND.0b013e31826f0d99.

New titin (connectin) isoforms and their functional role in striated muscles of mammals: facts and suppositions

Vikhlyantsev IM, Podlubnaya ZA.

Biochemistry (Mosc). 2012 Dec;77(13):1515-35. doi: 10.1134/S0006297912130093.

Guidelines for the use of intravenous immunoglobulin in the treatment of neurologic diseases

Bascić-Kes V, Kes P, Zavoreo I, Lisak M, Zadro L, Corić L, Demarin V; Ad Hoc Comittee of the Croatian Society for Neurovascular Disorders, Croatian Medical Association.

Acta Clin Croat. 2012 Dec;51(4):673-83.

Racial differences in restless legs symptoms and serum ferritin in an incident dialysis patient cohort

Kutner NG, Zhang R, Huang Y, Bliwise DL.

Int Urol Nephrol. 2012 Dec;44(6):1825-31. doi: 10.1007/s11255-011-0108-6. Epub 2012 Jan 5.

In vivo mesolimbic D2/3 receptor binding predicts posttherapeutic clinical responses in restless legs syndrome: a positron emission tomography study

Oboshi Y, Ouchi Y, Yagi S, Kono S, Nakai N, Yoshikawa E, Futatsubashi M, Terada T, Kim K, Harada K.

J Cereb Blood Flow Metab. 2012 Apr;32(4):654-62. doi: 10.1038/jcbfm.2011.201. Epub 2012 Jan 11.

[Restless legs syndrome - a review]

Sveinsson OA, Sigurdsson AP.

Laeknabladid. 2012 Jan;98(1):33-7. doi: 10.17992/lbl.2012.01.410.

Restless legs syndrome--theoretical roles of inflammatory and immune mechanisms

Weinstock LB, Walters AS, Paueksakon P.

Sleep Med Rev. 2012 Aug;16(4):341-54. doi: 10.1016/j.smrv.2011.09.003. Epub 2012 Jan 17.

Restless legs syndrome in dialysis patients: a comparison between hemodialysis and continuous ambulatory peritoneal dialysis

Merlino G, Lorenzut S, Romano G, Sommaro M, Fontana A, Montanaro D, Valente M, Gigli GL.

Neurol Sci. 2012 Dec;33(6):1311-8. doi: 10.1007/s10072-012-0953-9. Epub 2012 Jan 22.

Efficacy and safety of dopamine agonists in restless legs syndrome

Hornyak M, Trenkwalder C, Kohnen R, Scholz H.

Sleep Med. 2012 Mar;13(3):228-36. doi: 10.1016/j.sleep.2011.09.013. Epub 2012 Jan 27.

Toward an animal model of restless legs syndrome?

Ghorayeb I, Bezard E.

Mov Disord. 2012 Mar;27(3):337-8. doi: 10.1002/mds.24905. Epub 2012 Jan 30.

Gabapentin enacarbil for treatment of restless legs syndrome in adults

Hayes WJ, Lemon MD, Farver DK.

Ann Pharmacother. 2012 Feb;46(2):229-39. doi: 10.1345/aph.1Q578. Epub 2012 Jan 31.

Cırcadian changes in cortical excitability in restless legs syndrome

Gündüz A, Adatepe NU, Kiziltan ME, Karadeniz D, Uysal O.

J Neurol Sci. 2012 May 15;316(1-2):122-5. doi: 10.1016/j.jns.2012.01.008. Epub 2012 Feb 2.

Efficacy of vitamins C, E, and their combination for treatment of restless legs syndrome in hemodialysis patients: a randomized, double-blind, placebo-controlled trial

Sagheb MM, Dormanesh B, Fallahzadeh MK, Akbari H, Sohrabi Nazari S, Heydari ST, Behzadi S.

Sleep Med. 2012 May;13(5):542-5. doi: 10.1016/j.sleep.2011.11.010. Epub 2012 Feb 7.

Evaluation of gabapentin enacarbil on cardiac repolarization: a randomized, double-blind, placebo- and active-controlled, crossover thorough QT/QTc study in healthy adults

Chen D, Lal R, Zomorodi K, Atluri H, Ho J, Luo W, Tovera J, Bonzo D, Cundy K.

Clin Ther. 2012 Feb;34(2):351-362.e3. doi: 10.1016/j.clinthera.2012.01.002.

Systematic evaluation of augmentation during treatment with ropinirole in restless legs syndrome (Willis-Ekbom disease): results from a prospective, multicenter study over 66 weeks

García-Borreguero D, Högl B, Ferini-Strambi L, Winkelman J, Hill-Zabala C, Asgharian A, Allen R.

Mov Disord. 2012 Feb;27(2):277-83. doi: 10.1002/mds.24889. Epub 2012 Jan 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias